- Home
- XENE vs NEA Comparison
XENE vs NEA Comparison
Compare XENE & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | NEA |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | XENE | NEA |
|---|---|---|
| Price | $42.28 | $11.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $54.09 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 803.4K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.74 | $9.20 |
| 52 Week High | $46.60 | $11.37 |
Technical Indicators
Market Signals| Indicator | XENE | NEA |
|---|---|---|
| Relative Strength Index (RSI) | 50.52 | 43.42 |
| Support Level | $40.81 | $11.55 |
| Resistance Level | $43.14 | $11.83 |
| Average True Range (ATR) | 1.90 | 0.07 |
| MACD | 0.09 | -0.03 |
| Stochastic Oscillator | 66.89 | 22.86 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.